Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Stem cell collection method tested for rare blood disorders

NCT ID NCT07585136

First seen May 13, 2026 · Last updated Jun 18, 2026 · Updated 3 times

Summary

This early-stage study tests whether it is safe and possible to collect blood stem cells from 12 people aged 18-25 with bone marrow failure syndromes. Participants receive two drugs (Filgrastim and plerixafor) to move stem cells into the bloodstream, where they are collected. The goal is to gather enough healthy stem cells to advance gene therapy for these life-threatening conditions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE MARROW FAILURE SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Saint Jude Children's Research Hospital

    Memphis, Tennessee, 38105-2794, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

Bone Marrow Failure Disorders bone marrow failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.